首页> 美国卫生研究院文献>Stem Cell Research Therapy >Fate determination in mesenchymal stem cells: a perspective from histone-modifying enzymes
【2h】

Fate determination in mesenchymal stem cells: a perspective from histone-modifying enzymes

机译:间充质干细胞的命运确定:组蛋白修饰酶的角度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mesenchymal stem cells (MSCs) hold great promise for therapeutic use in regenerative medicine and tissue engineering. A detailed understanding of the molecular processes governing MSC fate determination will be instrumental in the application of MSCs. Much progress has been made in recent years in defining the epigenetic events that control the differentiation of MSCs into different lineages. A complex network of transcription factors and histone modifiers, in concert with specific transcriptional co-activators and co-repressors, activates or represses MSC differentiation. In this review, we summarize recent progress in determining the effects of histone-modifying enzymes on the multilineage differentiation of MSCs. In addition, we propose that the manipulation of histone signatures associated with lineage-specific differentiation by small molecules has immense potential for the advancement of MSC-based regenerative medicine.
机译:间充质干细胞(MSCs)在再生医学和组织工程中具有广阔的治疗前景。对控制MSC命运确定的分子过程的详细理解将有助于MSC的应用。近年来,在定义控制MSC分化为不同谱系的表观遗传事件方面已经取得了很大进展。转录因子和组蛋白修饰剂的复杂网络与特定的转录共激活因子和共抑制因子共同作用,可以激活或抑制MSC分化。在这篇综述中,我们总结了确定组蛋白修饰酶对MSCs多向分化的影响的最新进展。此外,我们建议通过小分子操纵与谱系特异性分化相关的组蛋白签名对于基于MSC的再生医学的发展具有巨大的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号